Role of colonoscopy in colorectal cancer screening: Available evidence.

[1]  M. Hoffmeister,et al.  Prevalence of Colorectal Neoplasia 10 or More Years After a Negative Screening Colonoscopy in 120 000 Repeated Screening Colonoscopies , 2023, JAMA internal medicine.

[2]  Eric A. Miller,et al.  15-Year Benefits of Sigmoidoscopy Screening on Colorectal Cancer Incidence and Mortality , 2022, Annals of Internal Medicine.

[3]  M. Hernán,et al.  Effect of Colonoscopy Screening on Risks of Colorectal Cancer and Related Death. , 2022, The New England journal of medicine.

[4]  Aung Ko Win,et al.  Colorectal cancer incidences in Lynch syndrome: a comparison of results from the prospective lynch syndrome database and the international mismatch repair consortium , 2022, Hereditary Cancer in Clinical Practice.

[5]  G. Nguyen,et al.  AGA Clinical Practice Update on Endoscopic Surveillance and Management of Colorectal Dysplasia in Inflammatory Bowel Diseases: Expert Review. , 2021, Gastroenterology.

[6]  Amy B. Knudsen,et al.  Colorectal Cancer Screening: An Updated Modeling Study for the US Preventive Services Task Force. , 2021, JAMA.

[7]  M. Cabana,et al.  Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement. , 2021, JAMA.

[8]  Jennifer S. Lin,et al.  Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. , 2021, JAMA.

[9]  M. Rugge,et al.  Non-compliance with colonoscopy after a positive faecal immunochemical test doubles the risk of dying from colorectal cancer , 2021, Gut.

[10]  Charles J. Kahi,et al.  ACG Clinical Guidelines: Colorectal Cancer Screening 2021. , 2021, The American journal of gastroenterology.

[11]  A. Jemal,et al.  Cancer Statistics, 2021 , 2021, CA: a cancer journal for clinicians.

[12]  R. Siegel,et al.  Contributions of Adenocarcinoma and Carcinoid Tumors to Early-Onset Colorectal Cancer Incidence Rates in the United States , 2020, Annals of Internal Medicine.

[13]  M. Kaminski,et al.  Participation in Competing Strategies for Colorectal Cancer Screening - a Randomized Health Services Study (PICCOLINO Study). , 2020, Gastroenterology.

[14]  A. Barkun,et al.  Association Between Time to Colonoscopy After Positive Fecal Testing and Colorectal Cancer Outcomes: A Systematic Review , 2020, Clinical Gastroenterology and Hepatology.

[15]  M. Kaminski,et al.  Long-Term Colorectal Cancer Incidence and Mortality After a Single Negative Screening Colonoscopy , 2020, Annals of Internal Medicine.

[16]  L. López-Rosés,et al.  Clinical validation of risk-scoring systems to predict risk of delayed bleeding after endoscopic mucosal resection of large colorectal lesions. , 2020, Gastrointestinal endoscopy.

[17]  E. Kuipers,et al.  Diagnostic Yield of One-Time Colonoscopy vs One-Time Flexible Sigmoidoscopy vs Multiple Rounds of Mailed Fecal Immunohistochemical Tests in Colorectal Cancer Screening. , 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[18]  A. Cheifetz,et al.  Meta-analysis of Virtual-based Chromoendoscopy Compared With Dye-spraying Chromoendoscopy Standard and High-definition White Light Endoscopy in Patients With Inflammatory Bowel Disease at Increased Risk of Colon Cancer. , 2020, Inflammatory bowel diseases.

[19]  H. Brenner,et al.  Effect of Sex, Age and Positivity Threshold on Fecal Immunochemical Test Accuracy: a Systematic Review and Meta-Analysis. , 2019, Gastroenterology.

[20]  I. Tomlinson,et al.  Guidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)/Association of Coloproctology of Great Britain and Ireland (ACPGBI)/United Kingdom Cancer Genetics Group (UKCGG) , 2019, Gut.

[21]  C. Hassan,et al.  Advanced imaging for detection and differentiation of colorectal neoplasia: European Society of Gastrointestinal Endoscopy (ESGE) Guideline – Update 2019 , 2019, Endoscopy.

[22]  M. Kaminski,et al.  Endoscopic management of Lynch syndrome and of familial risk of colorectal cancer: European Society of Gastrointestinal Endoscopy (ESGE) Guideline , 2019, Endoscopy.

[23]  E. Steyerberg,et al.  Effects of Family History on Relative and Absolute Risks for Colorectal Cancer: a Systematic Review and Meta-Analysis. , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[24]  A. Cheifetz,et al.  Meta-analysis of dye-based chromoendoscopy compared with standard- and high-definition white-light endoscopy in patients with inflammatory bowel disease at increased risk of colon cancer. , 2019, Gastrointestinal endoscopy.

[25]  M. Kaminski,et al.  Endoscopic management of polyposis syndromes: European Society of Gastrointestinal Endoscopy (ESGE) Guideline , 2019, Endoscopy.

[26]  C. Hassan,et al.  Bowel preparation for colonoscopy: European Society of Gastrointestinal Endoscopy (ESGE) Guideline – Update 2019 , 2019, Endoscopy.

[27]  Xuan Wang,et al.  Systematic review with meta‐analysis: Chromoendoscopy versus white light endoscopy in detection of dysplasia in patients with inflammatory bowel disease , 2019, Journal of digestive diseases.

[28]  Christopher D. Jensen,et al.  Long-term Risk of Colorectal Cancer and Related Deaths After a Colonoscopy With Normal Findings , 2019, JAMA internal medicine.

[29]  M. Kloor,et al.  No Difference in Colorectal Cancer Incidence or Stage at Detection by Colonoscopy Among 3 Countries With Different Lynch Syndrome Surveillance Policies. , 2018, Gastroenterology.

[30]  A. Barkun,et al.  Clinical Practice Guideline on Screening for Colorectal Cancer in Individuals With a Family History of Nonhereditary Colorectal Cancer or Adenoma: The Canadian Association of Gastroenterology Banff Consensus. , 2018, Gastroenterology.

[31]  Jie He,et al.  Participation and yield of a population-based colorectal cancer screening programme in China , 2018, Gut.

[32]  J. Emery,et al.  Revised Australian national guidelines for colorectal cancer screening: family history , 2018, The Medical journal of Australia.

[33]  C. Flowers,et al.  Colorectal cancer screening for average‐risk adults: 2018 guideline update from the American Cancer Society , 2018, CA: a cancer journal for clinicians.

[34]  A. Tsapas,et al.  Diagnostic Accuracy of Fecal Immunochemical Test in Patients at Increased Risk for Colorectal Cancer: A Meta-analysis , 2017, JAMA internal medicine.

[35]  David Lieberman,et al.  Colorectal cancer screening: Recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer. , 2017, Gastrointestinal endoscopy.

[36]  P. Møller,et al.  Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database , 2017, Gut.

[37]  E. Van Cutsem,et al.  Virtual chromoendoscopy (I-SCAN) detects more polyps in patients with Lynch syndrome: a randomized controlled crossover trial , 2017, Endoscopy.

[38]  M. Bretthauer,et al.  Effectiveness of Screening Colonoscopy to Prevent Colorectal Cancer Among Medicare Beneficiaries Aged 70 to 79 Years , 2016, Annals of Internal Medicine.

[39]  Á. Lanas,et al.  Risk of Advanced Neoplasia in First-Degree Relatives with Colorectal Cancer: A Large Multicenter Cross-Sectional Study , 2016, PLoS medicine.

[40]  S. Berndt,et al.  Incidence and mortality of colorectal cancer in individuals with a family history of colorectal cancer. , 2015, Gastroenterology.

[41]  L. Lipton,et al.  Familial colorectal cancer , 2015, Internal medicine journal.

[42]  D. Nicolás-Pérez,et al.  Equivalency of fecal immunochemical tests and colonoscopy in familial colorectal cancer screening. , 2014, Gastroenterology.

[43]  H. Brenner,et al.  Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies , 2014, BMJ : British Medical Journal.

[44]  D. Evans,et al.  Systematic review of the impact of registration and screening on colorectal cancer incidence and mortality in familial adenomatous polyposis and Lynch syndrome , 2013, The British journal of surgery.

[45]  Jasmin A. Tiro,et al.  Comparative effectiveness of fecal immunochemical test outreach, colonoscopy outreach, and usual care for boosting colorectal cancer screening among the underserved: a randomized clinical trial. , 2013, JAMA Internal Medicine.

[46]  Reiko Nishihara,et al.  Long-term colorectal-cancer incidence and mortality after lower endoscopy. , 2013, The New England journal of medicine.

[47]  J. Hopper,et al.  Screening participation predictors for people at familial risk of colorectal cancer: a systematic review. , 2013, American journal of preventive medicine.

[48]  N. Suzuki,et al.  Narrow Band Imaging for Detection of Dysplasia in Colitis: A Randomized Controlled Trial , 2012, The American Journal of Gastroenterology.

[49]  Á. Lanas,et al.  Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. , 2012, The New England journal of medicine.

[50]  Joyce A. Mitchell,et al.  Comparison of compliance for colorectal cancer screening and surveillance by colonoscopy based on risk , 2011, Genetics in Medicine.

[51]  H. Morreau,et al.  MUTYH-associated polyposis (MAP). , 2011, Critical reviews in oncology/hematology.

[52]  T. Tuohy,et al.  Hereditary and familial colon cancer. , 2010, Gastroenterology.

[53]  Antoni Castells,et al.  Low adherence to colonoscopy in the screening of first-degree relatives of patients with colorectal cancer , 2007, Gut.

[54]  P. Bampton,et al.  A comparison of colorectal neoplasia screening tests: a multicentre community‐based study of the impact of consumer choice , 2006 .

[55]  L. Bisanti,et al.  Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates. , 2005, Journal of the National Cancer Institute.

[56]  M. Leppert,et al.  Genetic testing and phenotype in a large kindred with attenuated familial adenomatous polyposis. , 2004, Gastroenterology.

[57]  L. Aaltonen,et al.  Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. , 2000, Gastroenterology.

[58]  P. Sistonen,et al.  Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer. , 1995, Gastroenterology.